These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 3'-Azido-3'-deoxythymidine prevents induction of murine acquired immunodeficiency syndrome in C57BL/10 mice infected with LP-BM5 murine leukemia viruses, a possible animal model for antiretroviral drug screening. Ohnota H; Okada Y; Ushijima H; Kitamura T; Komuro K; Mizuochi T Antimicrob Agents Chemother; 1990 Apr; 34(4):605-9. PubMed ID: 1693056 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of murine AIDS by alternate administration of azidothymidine and fludarabine monophosphate. Fraternale A; Casabianca A; Tonelli A; Vallanti G; Chiarantini L; Brandi G; Celeste AG; Magnani M J Acquir Immune Defic Syndr; 2000 Mar; 23(3):209-20. PubMed ID: 10839656 [TBL] [Abstract][Full Text] [Related]
4. Intermittent, alternating, and concurrent regimens of zidovudine and 2'-3' dideoxycytidine in the LP-BM5 murine induced immunodeficiency model. Basham T; Holdener T; Merigan T J Infect Dis; 1991 Apr; 163(4):869-72. PubMed ID: 1849164 [TBL] [Abstract][Full Text] [Related]
5. Effect of cyclophosphamide, total body irradiation, and zidovudine on retrovirus proliferation and disease progression in murine AIDS. Klinman DM; Krieg A; Conover J; Ussery MA; Black PL AIDS Res Hum Retroviruses; 1992 Jan; 8(1):101-6. PubMed ID: 1310603 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate. Fraternale A; Casabianca A; Rossi L; Chiarantini L; Brandi G; Aluigi G; Schiavano GF; Magnani M J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):164-73. PubMed ID: 8680888 [TBL] [Abstract][Full Text] [Related]
7. Repeated cycles of alternate administration of fludarabine and Zidovudine plus Didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels. Fraternale A; Casabianca A; Orlandi C; Chiarantini L; Brandi G; Silvestri G; Magnani M Virology; 2002 Oct; 302(2):354-62. PubMed ID: 12441079 [TBL] [Abstract][Full Text] [Related]
8. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS. Green KA; Noelle RJ; Green WR Virology; 1998 Feb; 241(2):260-8. PubMed ID: 9499800 [TBL] [Abstract][Full Text] [Related]
9. Factors influencing zidovudine efficacy when administered at early stages of Friend virus infection in mice. Sinet M; Desforges B; Launay O; Colin JN; Pocidalo JJ Antiviral Res; 1991 Sep; 16(2):163-71. PubMed ID: 1799277 [TBL] [Abstract][Full Text] [Related]
10. Effects of Standardized Eriobotrya japonica Extract in LP-BM5 Murine Leukemia Viruses-Induced Murine Immunodeficiency Syndrome. Kim OK; Nam DE; Jun W; Lee J Immunol Invest; 2016; 45(2):148-60. PubMed ID: 26854821 [TBL] [Abstract][Full Text] [Related]
12. 3'-Azido-3'-deoxythymidine ameliorates the thrombocytopenia observed in a murine model of AIDS. Chow FP; Sutton PA; Hamburger AW Exp Hematol; 1990 Oct; 18(9):1038-41. PubMed ID: 2168839 [TBL] [Abstract][Full Text] [Related]
13. Methionine enkephalin combined with AZT therapy reduce murine retrovirus-induced disease. Specter S; Plotnikoff N; Bradley WG; Goodfellow D Int J Immunopharmacol; 1994 Nov; 16(11):911-7. PubMed ID: 7868296 [TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of the anemia induced by azidothymidine (AZT) in a murine model of AIDS. Chow FP; Hamburger AW Eur J Haematol; 1991 Aug; 47(2):91-7. PubMed ID: 1889487 [TBL] [Abstract][Full Text] [Related]
16. In vivo tissue disposition of 3'-azido-3'-deoxythymidine and its anabolites in control and retrovirus-infected mice. Chow HH; Li P; Brookshier G; Tang Y Drug Metab Dispos; 1997 Apr; 25(4):412-22. PubMed ID: 9107539 [TBL] [Abstract][Full Text] [Related]
17. Effect of 3'azidothymidine administered in drinking water or by continuous infusion on the development of MAIDS. Eiseman JL; Yetter RA; Fredrickson TN; Shapiro SG; MacAuley C; Bilello JA Antiviral Res; 1991 Dec; 16(4):307-26. PubMed ID: 1663732 [TBL] [Abstract][Full Text] [Related]
18. Time-dependent changes induced by azidothymidine in erythroid progenitor colonies in immunodeficient mice. Chow FP; Hamburger AW Exp Hematol; 1992 Feb; 20(2):245-50. PubMed ID: 1544395 [TBL] [Abstract][Full Text] [Related]
19. Tissue disposition of zidovudine and its phosphorylated metabolites in zidovudine-treated healthy and retrovirus infected mice. Chow HH; Brookshier G; Li P Pharm Res; 1998 Jan; 15(1):139-44. PubMed ID: 9487561 [TBL] [Abstract][Full Text] [Related]
20. Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome. Phillips NC; Tsoukas C Blood; 1992 Mar; 79(5):1137-43. PubMed ID: 1371411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]